A novel Sry-downstream cellular event which preserves the readily available energy source of glycogen in mouse sex differentiation

J Cell Sci. 2005 Apr 1;118(Pt 7):1449-59. doi: 10.1242/jcs.01738. Epub 2005 Mar 15.

Abstract

Sry is transiently activated in pre-Sertoli cells of the gonadal ridge to initiate testis differentiation in mice. In pre-Sertoli cells, however, the cellular events induced immediately after the onset of Sry expression remain largely unknown. Here we show that testis-specific glycogen accumulation in pre-Sertoli cells is one of the earliest cellular events downstream of Sry action. In developing XY gonads, glycogen accumulation starts to occur in pre-Sertoli cells from around 11.15 dpc (tail somite 14 stage) in a center-to-pole pattern similar to the initial Sry expression profile. Glycogen accumulation was also found in XX male gonads of Sry-transgenic embryos, but not in XX female gonads of wildtype embryos at any developmental stage. In vitro analyses using various culture conditions suggest that testis-specific glycogen deposition is a tissue-autonomous event that can be induced even in serum-free conditions and in a culture of gonadal explants without adjacent mesonephros. Moreover, glycogen accumulation in pre-Sertoli cells was significantly inhibited in vitro by the PI3K inhibitor LY294002, but not by the MEK inhibitor PD98059. Active phospho-AKT (PI3K effector) showed a high degree of accumulation in gonadal somatic cells of genital ridges in a testis-specific manner, both in vitro and in vivo. Therefore, these findings suggest that immediately after the onset of Sry expression, activation of the PI3K-AKT pathway promotes testis-specific glycogen storage in pre-Sertoli cells. To the best of our knowledge, this is a novel Sry-downstream cellular event which preserves this readily available energy source in Sertoli cells for testis-specific morphogenesis and hormone production.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Busulfan / pharmacology
  • Cell Physiological Phenomena / drug effects*
  • Chromones / pharmacology
  • DNA-Binding Proteins / drug effects
  • DNA-Binding Proteins / genetics*
  • DNA-Binding Proteins / metabolism*
  • Energy Metabolism / drug effects
  • Energy Metabolism / physiology*
  • Enzyme Inhibitors / pharmacology
  • Female
  • Glycogen / antagonists & inhibitors
  • Glycogen / metabolism*
  • Injections, Intraperitoneal
  • Male
  • Mice
  • Mice, Inbred ICR
  • Mice, Transgenic
  • Morpholines / pharmacology
  • Nuclear Proteins / drug effects
  • Nuclear Proteins / genetics*
  • Nuclear Proteins / metabolism*
  • Organ Culture Techniques / methods
  • Organ Specificity / physiology
  • Sertoli Cells / metabolism
  • Sex Characteristics
  • Sex Determination Analysis
  • Sex Differentiation* / genetics
  • Sex-Determining Region Y Protein
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Testis / embryology
  • Testis / metabolism
  • Testis / ultrastructure
  • Transcription Factors / drug effects
  • Transcription Factors / genetics*
  • Transcription Factors / metabolism*

Substances

  • Chromones
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Morpholines
  • Nuclear Proteins
  • Sex-Determining Region Y Protein
  • Sry protein, mouse
  • Transcription Factors
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Glycogen
  • Busulfan